ACOR

Acorda Therapeutics, Inc.
ACOR

Overview Fund Activity
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

81 hedge funds and large institutions have $17.6M invested in Acorda Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 28 reducing their positions, and 44 closing their positions.

Holders
81
Holders Change
-26
Holders Change %
-24.3%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
14
Reduced
28
Closed
44
Calls
$101K
Puts
$2.41M
Net Calls
-$2.31M
Net Calls Change
+$1.38M

Top Buyers

1
Arrowstreet Capital
1
Arrowstreet Capital
Massachusetts
$429K
2
Millennium Management
2
Millennium Management
New York
$478K
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$1.38M
4
Jane Street
4
Jane Street
New York
$191K
5
PP
5
Paloma Partners
Connecticut
$175K

Top Sellers

1
BlackRock
1
BlackRock
New York
$840K
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$464K
3
PHS
3
PFM Health Sciences
California
$0
4
State Street
4
State Street
Massachusetts
$27K
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$1.4M
Name Market Value Shares Shares
Change 		Shares
Change %
HT
126
HAP Trading
New York
– – – –
WVP
127
Worth Venture Partners
New Jersey
– – – –
CFGS
128
Concourse Financial Group Securities
Alabama
– – – –
CAC
129
Cowen and Company
New York
– – – –
CG
130
Cutler Group
California
$0 700 – –
PFBT
131
Parkside Financial Bank & Trust
Missouri
$0 638 +638 New
2 3 4 5
6